Article
Strategies for neoantigen screening and immunogenicity validation in cancer immunotherapy (Review)
7 May 2025
Abstract excerpt
Cancer immunotherapy stimulates and enhances antitumor immune responses to eliminate cancer cells. Neoantigens, which originate from specific mutations within tumor cells, are key targets in cancer immunotherapy. Neoantigens manifest as abnormal peptide fragments or protein segments that are uniquely expressed in tumor cells, making them highly immunogenic. As a result, they activate the immune system,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
